Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
Multimodal CIPN therapy helps manage CIPN. Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most painful side effects of chemotherapy for the treatment of myeloma.
CIPN ranges from minimal, temporary tingling to full on, permanent nerve pain. Conventional treatments for CIPN are hit and miss with serious possible side effects.
In my experience as a long-term MM survivor who has studied this side effect of MM chemo for years, work with your oncologist to manage chemo vacations, dose reductions and combine this effort with non-conventional therapies discussed below.
Email me at David.PeopleBeatingCancer@gmail.com with questions about managing multiple myeloma.
Thank you,
David Emerson
A common side effect post chemotherapy is chemotherapy-induced peripheral neuropathy (CIPN). The purpose of this study was to investigate the effect of a multimodal exercise program compared to standard physical therapy in treating CIPN symptoms and improving daily living skills.
The aim of this study was to evaluate the effect of multimodal therapeutic exercises and their role in mitigating CIPN symptoms on the neuropathy score and instrumental activities of daily living.
Seventy-eight participants were divided into two groups: multimodal exercise program (Group A) and standard physical therapy (Group B) who fulfilled the inclusion criteria of age 25-55 years with CIPN (grade 2 or 3). Pre- and post-assessment was done using the modified Total Neuropathy Score (mTNS) and Lawton Instrumental Activities of Daily Living Scale (L-IADL)
A significant improvement in the mTNS was seen in Group A (14.68 ± 1.66 to 7.03 ± 1.49, p<0.0001) compared to Group B (14.98 ± 1.54 to 13.66 ± 1.34, p=0.00116). L-IADL scores also showed more improvement in Group A (7.54 to 11.23, p<0.0001) versus Group B (5.51 to 7.35, p=0.001). A statistically significant improvement was seen (p<0.0001) for both outcome measures post-intervention….
The result of the present study correlates with the study of Zimmer et al. who proved that a multimodal therapeutic exercise had a significant role in the improvement of balance, strength, and QOL; thus an overall improvement in these outcomes might also have resulted in improvement in the activities of daily living [14].
The present study focuses on the protocol which focuses on
thus due to a multimodal approach, there is reduction in the symptoms of CIPN which in turn might have an improvement in the IADL. Another factor might be the focus on strength training which improved the strength of muscles thus helping in improving the instrumental activities of daily living.
Thus, from the findings of the present study, it can be concluded that the multimodal therapeutic exercise program helps to reduce the symptoms of CIPN and improve the IADL.
However, the multimodal therapeutic exercise program which focuses on a multidimensional treatment approach of aerobic exercises, resistance training, and balance training helps to reduce the symptoms of CIPN and improve the IADL more effectively.”